Aastrom

Developing autologous stem cell products for use in regenerative medicine

(1989)

Location:
Ann Arbor, MI

Management:
Timothy M. Mayleben, CEO

UM Inventor(s):
Bernhard O. Palsson

Funding parties:
EDF Ventures

IPO:
1997 [NASDAQ:ASTM]